Identification | Back Directory | [Name]
KHK-IN-5 | [CAS]
3043939-40-5 | [Synonyms]
KHK-IN-5 3-Pyridinecarbonitrile, 4-(difluoromethyl)-6-[(3aR,6aS)-hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl]-2-[[2-(methylthio)phenyl]amino]-, rel- | [Molecular Formula]
C20H21F2N5S | [MOL File]
3043939-40-5.mol | [Molecular Weight]
401.48 |
Hazard Information | Back Directory | [Uses]
KHK-IN-5 (Compound 18) is a KHK inhibitor. KHK-IN-5 can be used for the research of nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), and type 2 diabetes (T2DM)[1]. | [References]
[1] Sabnis RW. Novel Cyanopyridine Compounds as KHK Inhibitors for Treating NAFLD, NASH, and Type II Diabetes. ACS Med Chem Lett. 2024 Jul 23;15(8):1191-1192. DOI:10.1021/acsmedchemlett.4c00332 |
|
|